Jennifer L. Horspool

“𝙄 𝙩𝙝𝙤𝙪𝙜𝙝𝙩 '𝙝𝙤𝙬 𝙝𝙖𝙧𝙙 𝙘𝙖𝙣 𝙞𝙩 𝙗𝙚 𝙩𝙤 𝙗𝙪𝙞𝙡𝙙 𝙖 𝙈𝙖𝙘𝙝𝙞𝙣𝙚 𝙇𝙚𝙖𝙧𝙣𝙞𝙣𝙜 𝙢𝙤𝙙𝙚𝙡'? 𝙄 𝙠𝙣𝙤𝙬 𝙩𝙝𝙚 𝙩𝙝𝙞𝙣𝙜𝙨 𝙄 𝙘𝙖𝙧𝙚 𝙖𝙗𝙤𝙪𝙩 𝙩𝙝𝙖𝙩 𝙘𝙤𝙪𝙡𝙙 𝙗𝙚 𝙞𝙣𝙛𝙡𝙪𝙚𝙣𝙘𝙞𝙣𝙜 𝙩𝙝𝙚 𝙤𝙪𝙩𝙘𝙤𝙢𝙚.. 𝙄 𝙙𝙚𝙘𝙞𝙙𝙚𝙙 𝙩𝙤 𝙨𝙩𝙖𝙧𝙩 𝙬𝙞𝙩𝙝 𝙢𝙤𝙧𝙚 𝙩𝙝𝙖𝙣 100 𝙫𝙖𝙧𝙞𝙖𝙗𝙡𝙚𝙨 𝙛𝙤𝙧 𝙖𝙗𝙤𝙪𝙩 100,000 𝙡𝙞𝙫𝙚𝙨, 𝙖𝙣𝙙 𝙄 𝙩𝙝𝙤𝙪𝙜𝙝𝙩, 𝙤𝙝, 𝙩𝙝𝙞𝙨 𝙬𝙞𝙡𝙡 𝙗𝙚 𝙠𝙞𝙣𝙙 𝙤𝙛 𝙚𝙖𝙨𝙮... 𝙒𝙚𝙡𝙡, 𝙗𝙚𝙛𝙤𝙧𝙚 𝙬𝙚 𝙬𝙚𝙧𝙚 𝙗𝙪𝙞𝙡𝙙𝙞𝙣𝙜, 𝙄 𝙨𝙖𝙞𝙙, ‘𝙊𝙆, 𝙬𝙚𝙡𝙡 𝙬𝙚 𝙜𝙤𝙩𝙩𝙖 𝙙𝙤 𝙤𝙪𝙧 𝙦𝙪𝙖𝙡𝙞𝙩𝙮 𝙘𝙝𝙚𝙘𝙠𝙨 𝙤𝙣 𝙩𝙝𝙚 𝙙𝙖𝙩𝙖, 𝙧𝙞𝙜𝙝𝙩?’... 𝙏𝙝𝙖𝙩 𝙥𝙧𝙤𝙘𝙚𝙨𝙨 𝙗𝙚𝙘𝙖𝙢𝙚 𝙖𝙡𝙢𝙤𝙨𝙩 𝙎𝙄𝙓 𝙢𝙤𝙣𝙩𝙝𝙨. 𝙎𝙤 𝙄 𝙬𝙖𝙨 𝙝𝙤𝙥𝙞𝙣𝙜 𝙩𝙝𝙖𝙩 𝙩𝙝𝙞𝙨 𝙩𝙬𝙤-𝙬𝙚𝙚𝙠 𝙥𝙧𝙤𝙟𝙚𝙘𝙩 - 𝙘𝙖𝙪𝙨𝙚 𝙧𝙚𝙖𝙡𝙡𝙮 𝙤𝙣𝙘𝙚 𝙮𝙤𝙪 𝙝𝙖𝙫𝙚 𝙩𝙝𝙚 𝙫𝙖𝙧𝙞𝙖𝙗𝙡𝙚𝙨 𝙖𝙣𝙙 𝙖𝙡𝙡 𝙩𝙝𝙚 𝙙𝙖𝙩𝙖 𝙤𝙪𝙩 - 𝙞𝙩'𝙨 𝙧𝙚𝙖𝙡𝙡𝙮 𝙡𝙞𝙠𝙚 𝙟𝙪𝙨𝙩 𝙥𝙡𝙪𝙜 𝙖𝙣𝙙 𝙘𝙝𝙪𝙜, 𝙧𝙞𝙜𝙝𝙩? ... 𝘽𝙪𝙩 𝙞𝙩'𝙨 𝙖𝙘𝙩𝙪𝙖𝙡𝙡𝙮 𝙩𝙝𝙚 𝙙𝙖𝙩𝙖 𝙘𝙡𝙚𝙖𝙣𝙞𝙣𝙜 𝙩𝙝𝙖𝙩 𝙞𝙨 𝙧𝙚𝙖𝙡𝙡𝙮 𝙙𝙞𝙛𝙛𝙞𝙘𝙪𝙡𝙩.” Amy Sitapati, CMIO for Population Health at UC San Diego Health, is one of those unique forces of nature whose enthusiasm for Healthcare, Tech and Informatics is simply contagious. When she brings so much energy to a conversation - even if if she’s moderating and not a panellist - you can’t help but get excited to take part. So I was so thrilled Amy was willing to bring her incredible insights and enthusiasm to The Digital Patient Podcast. We dig into: → How to navigate AI model validation and re-validation in a world of resource constraints → Why patient-level personalization and aligning with patient references for modalities is critical for digital patient engagement → The importance of doing the hard work to have clean, high quality, small data in order to build high quality AI models - and how AI agents could accelerate this process → Why clinicians need to get in the trenches and tinker with AI and how clinicians must take the lead on how AI should be shaped → Why UCSD created both AI governance and Data governance teams - and how this has simplified getting the right people in the room to ask the right questions … and much, much more! Link to the full episode in the comments 👇

30

5 Comments

The average rare disease patient spends 7–8 years just to get a diagnosis. Years of uncertainty, misdiagnoses, and searching for answers. And then — finally — a specialist identifies a treatment. It's FDA-approved. It's medically necessary. And an insurance company says no. AB 1887 (Assemblymember Rick Zbur) removes prior authorization and step therapy requirements for rare disease treatments — ensuring that when medicine has an answer, patients can actually reach it. Every rare disease patient deserves access to life-saving treatment.

7

Healthcare providers are on the front lines as healthcare is engulfed in a crisis of trust, culture wars and misinformation. Use social media to fight misinformation and rebuild trust in medicine, says top physician creator Dr. Mikhail Varshavski, who has attracted millions of followers — 5.1 million on Instagram and 14.4 million on YouTube — with interesting educational content, expert interviews, and insights to help break down misinformation. Dr. Mike encourages healthcare providers to add social media skills to their toolkit. Being as unbiased and nonpartisan as possible is key to building a trusting community. “We’ve proven that social media can be a place where you can make meaningful connection, you can find communities, you can get good information in a relatable, transparent way. I hope that this could be a wake-up call for us in the healthcare space, understanding that if we’re choosing not to be there for our patients, what’s going to happen is the void will be filled by bad actors, grifters and snake oil salesmen who will take advantage of our patients and misguide them.” Read the full Healio interview. #healthcare #misinformation #disinformation #socialmedia #physiciancreators

1

1 Comment

What happens when oncology leaders from Canada, Mexico, and the U.S. come together to tackle one of cancer care’s toughest challenges—rural access? At ACCC’s second Global eXchange panel, the conversation was clear: geography should never determine the quality of care a patient receives. The session revealed striking realities: patients flying hundreds of miles for treatment, Indigenous communities facing language barriers, and fragmented health systems delaying diagnoses for months. Yet, it also showcased hope—shared solutions that transcend borders. From patient navigation programs and culturally tailored outreach to telehealth and rotating clinics, these strategies are proving that collaboration works. The ACCC Global eXchange isn’t just a discussion—it’s a movement to share lessons across health systems and empower oncology professionals to build equitable care models. Whether you’re in a rural U.S. county or a remote Canadian territory, these insights can help you close gaps and improve outcomes. Read the full article and discover how global collaboration is shaping the future of rural oncology care: https://lnkd.in/eTqAHeVt? Association of Cancer Care Centers Rania Emara Enrique Soto Perez de Celis

10